Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04364620
Title AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alethia Biotherapeutics
Indications

lung non-small cell carcinoma

Therapies

AB-16B5 + Docetaxel

Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
The University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Centre Hospitalier de l'Université de Montréal (CHUM) Recruiting Montréal Quebec H2X 3E4 Canada Details
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Recruiting Québec Quebec G1V 4G5 Canada Details
Centre Intégré de Santé et de Services Sociaux des Laurentides (Hôpital Régional de St-Jérôme) Recruiting Saint-Jérôme Quebec J7Z 5T3 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field